TD Private Client Wealth’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.24M | Sell |
39,472
-1,304
| -3% | -$140K | 0.1% | 144 |
|
|
2025
Q1 | $4.11M | Buy |
40,776
+1,569
| +4% | +$158K | 0.11% | 126 |
|
|
2024
Q4 | $3.5M | Sell |
39,207
-11,791
| -23% | -$1.05M | 0.1% | 149 |
|
|
2024
Q3 | $4.27M | Sell |
50,998
-389
| -0.8% | -$32.6K | 0.12% | 126 |
|
|
2024
Q2 | $3.96M | Sell |
51,387
-956
| -2% | -$73.6K | 0.12% | 124 |
|
|
2024
Q1 | $3.58M | Sell |
52,343
-27,018
| -34% | -$1.85M | 0.12% | 143 |
|
|
2023
Q4 | $4.59M | Sell |
79,361
-33,745
| -30% | -$1.95M | 0.17% | 109 |
|
|
2023
Q3 | $5.97M | Sell |
113,106
-8,999
| -7% | -$475K | 0.26% | 73 |
|
|
2023
Q2 | $6.6M | Sell |
122,105
-29,085
| -19% | -$1.57M | 0.29% | 68 |
|
|
2023
Q1 | $7.56M | Sell |
151,190
-9,079
| -6% | -$454K | 0.34% | 54 |
|
|
2022
Q4 | $7.42M | Sell |
160,269
-1,959
| -1% | -$90.6K | 0.35% | 55 |
|
|
2022
Q3 | $6.28M | Buy |
162,228
+14,673
| +10% | +$568K | 0.32% | 61 |
|
|
2022
Q2 | $5.5M | Buy |
147,555
+29,930
| +25% | +$1.12M | 0.27% | 81 |
|
|
2022
Q1 | $5.21M | Buy |
117,625
+10,417
| +10% | +$461K | 0.22% | 105 |
|
|
2021
Q4 | $4.55M | Buy |
107,208
+6,136
| +6% | +$261K | 0.19% | 123 |
|
|
2021
Q3 | $4.39M | Buy |
101,072
+20,383
| +25% | +$884K | 0.19% | 117 |
|
|
2021
Q2 | $3.45M | Buy |
80,689
+23,658
| +41% | +$1.01M | 0.15% | 157 |
|
|
2021
Q1 | $2.2M | Buy |
57,031
+2,449
| +4% | +$94.7K | 0.1% | 213 |
|
|
2020
Q4 | $1.96M | Sell |
54,582
-52,495
| -49% | -$1.89M | 0.1% | 217 |
|
|
2020
Q3 | $4.09M | Sell |
107,077
-10,610
| -9% | -$405K | 0.23% | 98 |
|
|
2020
Q2 | $4.13M | Buy |
117,687
+10,748
| +10% | +$377K | 0.24% | 87 |
|
|
2020
Q1 | $3.49M | Buy |
106,939
+11,682
| +12% | +$381K | 0.25% | 92 |
|
|
2019
Q4 | $4.31M | Buy |
+95,257
| New | +$4.31M | 0.26% | 91 |
|